{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T18:50:36Z","timestamp":1770835836619,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T00:00:00Z","timestamp":1609804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T00:00:00Z","timestamp":1609804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s10067-020-05524-3","type":"journal-article","created":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T07:03:03Z","timestamp":1609830183000},"page":"2193-2202","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The significance of serum 14-3-3\u03b7 level in rheumatoid arthritis patients"],"prefix":"10.1007","volume":"40","author":[{"given":"Dina Anas Abdel Hai","family":"Hussin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3676-462X","authenticated-orcid":false,"given":"Reham M.","family":"Shaat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shereen Salah","family":"Metwally","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manal","family":"Awad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,5]]},"reference":[{"issue":"5","key":"5524_CR1","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s00296-015-3415-x","volume":"36","author":"P Taylor","year":"2016","unstructured":"Taylor P, Moore A, Vasilescu R et al (2016) A structured literature review of the burden of illness and unmet needs in patients with rheumatoid arthritis: a current perspective. Rheumatol Int 36(5):685\u2013695","journal-title":"Rheumatol Int"},{"issue":"5","key":"5524_CR2","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.semarthrit.2012.09.003","volume":"42","author":"M Englbrecht","year":"2013","unstructured":"Englbrecht M, Kruckow M, Araujo E, Rech J, Schett G (2013) The interaction of physical function and emotional well-being in rheumatoid arthritis\u2014what is the impact on disease activity and coping? Semin Arthritis Rheum 42(5):482\u2013491","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"5524_CR3","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1097\/BOR.0000000000000036","volume":"26","author":"A Gizinski","year":"2014","unstructured":"Gizinski A, Fox D (2014) T cell subsets and their role in the pathogenesis of rheumatic disease. Curr Opin Rheumatol 26(2):204\u2013210","journal-title":"Curr Opin Rheumatol"},{"issue":"11","key":"5524_CR4","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.3899\/jrheum.141069","volume":"41","author":"F Pratesi","year":"2014","unstructured":"Pratesi F, Migliorini P (2014) Something old, something new: biomarkers in rheumatoid arthritis. J Rheumatol 41(11):2091\u20132093","journal-title":"J Rheumatol"},{"issue":"2","key":"5524_CR5","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.autrev.2012.05.007","volume":"12","author":"L Trouw","year":"2012","unstructured":"Trouw L, Mahler M (2012) Closing the serological gap: promising novel biomarkers for the early diagnosis of rheumatoid arthritis. Autoimmun Rev 12(2):318\u2013322","journal-title":"Autoimmun Rev"},{"issue":"1","key":"5524_CR6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1042\/BJ20091834","volume":"427","author":"C Johnson","year":"2010","unstructured":"Johnson C, Crowther S, Stafford M et al (2010) Bioinformatic and experimental survey of 14-3-3-binding sites. Biochem J 427(1):69\u201378","journal-title":"Biochem J"},{"issue":"3","key":"5524_CR7","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.semcancer.2006.03.007","volume":"16","author":"A Gardino","year":"2006","unstructured":"Gardino A, Smerdon S, Yaffe M (2006) Structural determinants of 14-3-3 binding specificities and regulation of subcellular localization of 14-3-3-ligand complexes: a comparison of the X-ray crystal structures of all human 14-3-3 isoforms. Semin Cancer Biol 16(3):173\u2013182","journal-title":"Semin Cancer Biol"},{"key":"5524_CR8","first-page":"S247","volume":"64","author":"A Marotta","year":"2012","unstructured":"Marotta A, van Kuijk W, Maksymowych W et al (2012) 14\u20133\u20133 Eta is a modifiable serum biomarker that marks adalimumab response in psoriatic arthritis. Arthritis Rheum 64:S247\u2013S247","journal-title":"Arthritis Rheum"},{"key":"5524_CR9","doi-asserted-by":"publisher","first-page":"S1305","DOI":"10.1002\/art.38792","volume":"66","author":"W Maksymowych","year":"2014","unstructured":"Maksymowych W, Wichuk S, Lambert R et al (2014) Autoantibodies to 14-3-3\u03b7 are novel biomarkers associated with inflammation and radiographic progression in ankylosing spondylitis. Arthritis Rheumatol 66:S1305","journal-title":"Arthritis Rheumatol"},{"issue":"85","key":"5524_CR10","first-page":"S35","volume":"32","author":"W Maksymowych","year":"2014","unstructured":"Maksymowych W, Marotta A (2014) 14-3-3\u03b7: a novel biomarker platform for rheumatoid arthritis. Clin Exp Rheumatol 32(85):S35\u2013S39","journal-title":"Clin Exp Rheumatol"},{"issue":"11","key":"5524_CR11","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.3899\/jrheum.131446","volume":"41","author":"W Maksymowych","year":"2014","unstructured":"Maksymowych W, Naides S, Bykerk V et al (2014) Serum 14-3-3 is a novel marker that complements current serological measurements to enhance detection of patients with rheumatoid arthritis. J Rheumatol 41(11):2104\u20132113","journal-title":"J Rheumatol"},{"issue":"9","key":"5524_CR12","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman A et al (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62(9):2569\u20132581","journal-title":"Arthritis Rheum"},{"issue":"1","key":"5524_CR13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"M Prevoo","year":"1995","unstructured":"Prevoo M, Van'T Hof M, Kuper H et al (1995) Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38(1):44\u201348","journal-title":"Arthritis Rheum"},{"issue":"10","key":"5524_CR14","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1093\/rheumatology\/keh297","volume":"43","author":"J Fransen","year":"2004","unstructured":"Fransen J, Creemers M, Van Riel P (2004) Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria. Rheumatology 43(10):1252\u20131255","journal-title":"Rheumatology"},{"issue":"1","key":"5524_CR15","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1093\/rheumatology\/41.1.38","volume":"41","author":"W Bardwell","year":"2002","unstructured":"Bardwell W, Nicassio P, Weisman M et al (2002) Rheumatoid arthritis severity scale: a brief, physician-completed scale not confounded by patient self report of psychological functioning. Rheumatology 41(1):38\u201345","journal-title":"Rheumatology"},{"issue":"5","key":"5524_CR16","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/art.20695","volume":"51","author":"B Bruce","year":"2004","unstructured":"Bruce B, Fries J (2004) Longitudinal comparison of the Health Assessment Questionnaire (HAQ) and the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Arthritis Rheum 51(5):730\u2013737","journal-title":"Arthritis Rheum"},{"issue":"10","key":"5524_CR17","first-page":"1976","volume":"22","author":"R Rau","year":"1995","unstructured":"Rau R, Herborn G (1995) A modified version of Larsen\u2019s scoring method to assess radiologic changes in rheumatoid arthritis. J Rheumatol 22(10):1976\u20131982","journal-title":"J Rheumatol"},{"issue":"6","key":"5524_CR18","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/0002-9343(56)90103-6","volume":"21","author":"J Singer","year":"1956","unstructured":"Singer J, Plotz C (1956) The latex fixation test. Am J Med 21(6):888\u2013892","journal-title":"Am J Med"},{"issue":"1","key":"5524_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar2903","volume":"12","author":"GJ Pruijn","year":"2010","unstructured":"Pruijn GJ, Wiik A, van Venrooij W (2010) The use of citrullinated peptides and proteins for the diagnosis of rheumatoid arthritis. Arthritis Res Ther 12(1):1\u20138","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"5524_CR20","first-page":"1650","volume":"34","author":"R Kilani","year":"2007","unstructured":"Kilani R, Maksymowych W, Aitken A, Boire G, St-Pierre Y, Li Y, Ghahary A (2007) Detection of high levels of 2 specific isoforms of 14-3-3 proteins in synovial fluid from patients with joint inflammation. J Rheumatol 34(8):1650\u20131657","journal-title":"J Rheumatol"},{"key":"5524_CR21","first-page":"3723","volume":"67","author":"C Hitchon","year":"2015","unstructured":"Hitchon C, Smolik I, Meng X et al (2015) Serum 14-3-3eta are elevated in indigenous North Americans with rheumatoid arthritis and may predict imminent synovitis in their at-risk first degree relatives. Arthritis Rheumatol 67:3723\u20133724","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"5524_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-016-0935-z","volume":"18","author":"N Carrier","year":"2016","unstructured":"Carrier N, Marotta A, De Brum-Fernandes A et al (2016) Serum levels of 14-3-3\u03b7 protein supplement C-reactive protein and rheumatoid arthritis-associated antibodies to predict clinical and radiographic outcomes in a prospective cohort of patients with recent-onset inflammatory polyarthritis. Arthritis Res Ther 18(1):1\u201314","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"5524_CR23","doi-asserted-by":"publisher","first-page":"7309","DOI":"10.4049\/jimmunol.166.12.7309","volume":"166","author":"C Thery","year":"2001","unstructured":"Thery C, Boussac M, Veron P et al (2001) Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J Immunol 166(12):7309\u20137318","journal-title":"J Immunol"},{"issue":"8","key":"5524_CR24","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.3899\/jrheum.090346","volume":"36","author":"W Maksymowych","year":"2009","unstructured":"Maksymowych W, Landewe R, Tak P et al (2009) Reappraisal of OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage endpoints in rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis: the OMERACT 9 v2 criteria. J Rheumatol 36(8):1785\u20131791","journal-title":"J Rheumatol"},{"issue":"1","key":"5524_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-015-0799-7","volume":"17","author":"S Hirata","year":"2015","unstructured":"Hirata S, Marotta A, Gui Y et al (2015) Serum 14-3-3\u03b7 level is associated with severity and clinical outcomes of rheumatoid arthritis, and its pretreatment level is predictive of DAS28 remission with tocilizumab. Arthritis Res Ther 17(1):1\u201310","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"5524_CR26","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.3899\/jrheum.150330","volume":"42","author":"S Naides","year":"2015","unstructured":"Naides S, Marotta A (2015) 14-3-3 in \u201cseronegative\u201d rheumatoid arthritis. J Rheumatol 42(10):1995\u20131995","journal-title":"J Rheumatol"},{"issue":"1","key":"5524_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-015-0906-9","volume":"18","author":"M Van Beers-Tas","year":"2016","unstructured":"Van Beers-Tas M, Marotta A, Boers M et al (2016) A prospective cohort study of 14-3-3\u03b7 in ACPA and\/or RF-positive patients with arthralgia. Arthritis Res Ther 18(1):1\u20137","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"5524_CR28","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1080\/14397595.2019.1637575","volume":"30","author":"N Hammam","year":"2020","unstructured":"Hammam N, Salah S, Kholef EF, Moussa EM, Marotta A (2020) 14-3-3\u03b7 Protein in serum and synovial fluid correlates with radiographic damage and progression in a longitudinal evaluation of patients with established rheumatoid arthritis. Mod Rheumatol 30(4):664\u2013670","journal-title":"Mod Rheumatol"},{"issue":"1","key":"5524_CR29","first-page":"57","volume":"49","author":"SZ Guan","year":"2019","unstructured":"Guan SZ, Yang YQ, Bai X, Wang Y, Feng KQ, Zhang HJ et al (2019) Serum 14-3-3\u03b7 could improve the diagnostic rate of rheumatoid arthritis and correlates to disease activity. Ann Clin Lab Sci 49(1):57\u201362","journal-title":"Ann Clin Lab Sci"},{"key":"5524_CR30","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.cca.2019.12.011","volume":"502","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Liang Y, Feng L, Cui L (2020) Diagnostic performance of 14-3-3\u03b7 and anti-carbamylated protein antibodies in rheumatoid arthritis in Han population of Northern China. Clin Chim Acta 502:102\u2013110","journal-title":"Clin Chim Acta"},{"key":"5524_CR31","first-page":"3169","volume":"67","author":"A Vasconcellos","year":"2015","unstructured":"Vasconcellos A, Chittalae S, Efthimiou P (2015) Does 14-3-3 Eta protein offer any additional diagnostic value in rheumatoid arthritis? Arthritis Rheumatol 67:3169\u20133170","journal-title":"Arthritis Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05524-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-020-05524-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05524-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T22:17:50Z","timestamp":1621030670000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-020-05524-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,5]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["5524"],"URL":"https:\/\/doi.org\/10.1007\/s10067-020-05524-3","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,5]]},"assertion":[{"value":"23 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}